Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |